Machine Learning-Based Multimodal Molecular Biomarkers for Predictive Health Analytics.

Area of Science:

• Computational biology and bioinformatics
• Medical informatics and health analytics
• Machine learning and artificial intelligence in healthcare

Background:

• Global health challenges include heart disease, cancer, diabetes, and neurological disorders, necessitating early detection and intervention.
• Complex diseases require sensitive, multimodal biomarkers and advanced analytical methods for accurate patient outcome prediction.
• Current healthcare analytics face limitations in handling the heterogeneity of diseases and clinical data.

Purpose of the Study:

• To investigate the efficacy of machine learning (ML) and deep learning (DL) techniques for early health analytics and disease prediction.
• To explore the integration of multimodal biomarkers (molecular protein, chemical, genetic) with ML features for improved accuracy.
• To evaluate modern DL techniques like TabNet and AutoInt alongside traditional ML and DL approaches.

Main Methods:

• A three-stage approach was employed, starting with healthcare importance and case studies.
• Comparison of traditional ML algorithms, traditional DL approaches, and advanced DL techniques (TabNet, AutoInt).
• Integration of molecular protein, chemical, and genetic data with novel ML features for predictive modeling.

Main Results:

• The proposed methodology, integrating multimodal biomarkers and advanced ML features, demonstrated significant improvements in predictive accuracy.
• Modern DL techniques showed promise in enhancing the analytical capabilities for complex health conditions.
• The study successfully highlighted the benefit of combining diverse data modalities for more robust health outcome prediction.

Conclusions:

• Machine learning and deep learning offer powerful tools for advancing early health analytics and disease monitoring.
• Multimodal biomarker integration is crucial for developing highly sensitive and accurate predictive models.
• The findings support the use of advanced AI techniques for personalized medicine and improved patient care.